Published in Acta Derm Venereol on January 21, 2002
Molecular signaling and targets from itch: lessons for cough. Cough (2013) 0.81
Advanced aging skin and itch: addressing an unmet need. Dermatol Ther (2013) 0.79
Elapid snake venom analyses show the specificity of the peptide composition at the level of genera Naja and Notechis. Toxins (Basel) (2014) 0.77
A critical role of cardiac fibroblast-derived exosomes in activating renin angiotensin system in cardiomyocytes. J Mol Cell Cardiol (2015) 0.76
A new high-resolution crystal structure of the Drosophila melanogaster angiotensin converting enzyme homologue, AnCE. FEBS Open Bio (2015) 0.75
Pruritus in the elderly: clinical approaches to the improvement of quality of life. P T (2012) 0.75
Acquired brachial cutaneous dyschromatosis in a 60-year-old male: a case report and review of the literature. Case Rep Dermatol Med (2014) 0.75
Synthesis, storage, and release of vascular endothelial growth factor/vascular permeability factor (VEGF/VPF) by human mast cells: implications for the biological significance of VEGF206. Mol Biol Cell (1998) 2.24
C3a and C5a stimulate chemotaxis of human mast cells. Blood (1997) 1.55
EAACI/GA2LEN/EDF guideline: definition, classification and diagnosis of urticaria. Allergy (2006) 1.55
Is a single oral dose of ivermectin sufficient in crusted scabies? Int J Dermatol (2001) 1.44
Expression of interleukin-8 detected by in situ hybridization correlates with worse prognosis in primary cutaneous melanoma. J Pathol (1999) 1.40
[Urticaria pigmentosa and mastocytosis]. Dtsch Med Wochenschr (1998) 1.38
EAACI/GA2LEN/EDF guideline: management of urticaria. Allergy (2006) 1.28
Mast cells and their mediators in cutaneous wound healing--active participants or innocent bystanders? Exp Dermatol (1999) 1.13
Acute urticaria: clinical aspects and therapeutic responsiveness. Acta Derm Venereol (1996) 1.10
Metastatic potential of human melanoma cells in nude mice--characterisation of phenotype, cytokine secretion and tumour-associated antigens. Br J Cancer (1996) 1.09
Miliaria crystallina in an intensive care setting. Clin Exp Dermatol (2004) 1.08
Identification of activating c-kit mutations in adult-, but not in childhood-onset indolent mastocytosis: a possible explanation for divergent clinical behavior. J Invest Dermatol (1998) 1.06
Membrane transport proteins associated with drug resistance expressed in human melanoma. Am J Pathol (1995) 1.04
Keratin 17 gene expression during the murine hair cycle. J Invest Dermatol (1997) 1.03
Topical calcitriol enhances normal hair regrowth but does not prevent chemotherapy-induced alopecia in mice. Cancer Res (1996) 1.02
Reversible binding of 5- and 8-methoxypsoralen to human serum proteins (albumin) and to epidermis in vitro. Br J Dermatol (1979) 1.02
Upregulation of TNF-alpha and IL-3 expression in lesional and uninvolved skin in different types of urticaria. J Allergy Clin Immunol (1999) 1.01
Inhibition of cytokine secretion from human leukemic mast cells and basophils by H1- and H2-receptor antagonists. Exp Dermatol (2000) 0.97
Mast cells and vasculature in atopic dermatitis--potential stimulus of neoangiogenesis. Allergy (2005) 0.97
Impact of vaccinations and infectious diseases on the risk of melanoma--evaluation of an EORTC case-control study. Eur J Cancer (2003) 0.97
Expression and functional activity of the IL-8 receptor type CXCR1 and CXCR2 on human mast cells. J Immunol (1998) 0.96
Molecular regulation of human IgE synthesis. J Mol Med (Berl) (1997) 0.95
Differential expression of angiotensin receptors in human cutaneous wound healing. Br J Dermatol (2005) 0.94
Mastocytosis: recent advances in defining the disease. Br J Dermatol (2001) 0.94
Human skin mast cells rapidly release preformed and newly generated TNF-alpha and IL-8 following stimulation with anti-IgE and other secretagogues. Exp Dermatol (2001) 0.94
Quantitative detection of soluble adhesion molecules in sera of melanoma patients correlates with clinical stage. Dermatology (1996) 0.93
Infections and melanoma risk: results of a multicentre EORTC case-control study. European Organization for Research and Treatment of Cancer. Melanoma Res (1999) 0.93
Release of stem cell factor from a human keratinocyte line, HaCaT, is increased in differentiating versus proliferating cells. J Invest Dermatol (1996) 0.92
Novel unconventional therapeutic approaches to atopic eczema. Dermatology (2000) 0.91
Evaluation of systemic provocation tests in patients with suspected allergic and pseudoallergic drug reactions. Acta Derm Venereol (1999) 0.91
Production of interleukin-6 by human mast cells and basophilic cells. J Invest Dermatol (1996) 0.91
Prior immunisation of patients with malignant melanoma with vaccinia or BCG is associated with better survival. An European Organization for Research and Treatment of Cancer cohort study on 542 patients. Eur J Cancer (2005) 0.91
Microscopic morphology of different types of urticaria. Arch Dermatol (1998) 0.90
Vaccination with IL-7 gene-modified autologous melanoma cells can enhance the anti-melanoma lytic activity in peripheral blood of patients with a good clinical performance status: a clinical phase I study. Br J Cancer (1998) 0.90
Erythema elevatum diutinum--evidence for disease-dependent leucocyte alterations and response to dapsone. Br J Dermatol (2000) 0.90
Retinoic acid inhibits CD40 + interleukin-4-mediated IgE production in vitro. Blood (1998) 0.90
Allopurinol: a therapeutic alternative for disseminated cutaneous sarcoidosis. Br J Dermatol (1996) 0.89
Definition, classification, and routine diagnosis of urticaria: a consensus report. J Investig Dermatol Symp Proc (2001) 0.89
Comparative cytokine gene expression: regulation and release by human mast cells. Immunology (1998) 0.89
Double-blind crossover study of high-dose cetirizine in cholinergic urticaria. Dermatology (1996) 0.89
The ascomycin macrolactam pimecrolimus (Elidel, SDZ ASM 981) is a potent inhibitor of mediator release from human dermal mast cells and peripheral blood basophils. J Allergy Clin Immunol (2001) 0.88
Laser-induced weal and flare reactions: clinical aspects and pharmacological modulation. Br J Dermatol (2002) 0.87
Detection of intracellular interleukin-8 in human mast cells: flow cytometry as a guide for immunoelectron microscopy. J Histochem Cytochem (1997) 0.87
Hair growth control by immunosuppression. Arch Dermatol Res (1996) 0.87
Human leukaemic (HMC-1) and normal skin mast cells express beta 2-integrins: characterization of beta 2-integrins and ICAM-1 on HMC-1 cells. Scand J Immunol (1997) 0.87
The transcription factor profile of human mast cells in comparison with monocytes and granulocytes. Cell Mol Life Sci (2005) 0.87
Mast cell chymase and tryptase during tissue turnover: analysis on in vitro mitogenesis of fibroblasts and keratinocytes and alterations in cutaneous scars. Exp Dermatol (1999) 0.86
Hair cycle-dependent changes in the gene expression and protein content of transforming factor beta 1 and beta 3 in murine skin. Arch Dermatol Res (1997) 0.86
A rapid method for measuring drug enrichment in epidermis. Arch Dermatol Res (1980) 0.86
Treatment of melanoma cells with the synthetic retinoid CD437 induces apoptosis via activation of AP-1 in vitro, and causes growth inhibition in xenografts in vivo. J Cell Biol (1996) 0.86
Expression of lymphotoxin-alpha by keratinocytes: a further mediator for the lichenoid reaction. Pathobiology (2000) 0.86
Crossreacting IgG antibodies against fox mite antigens in human scabies. Arch Dermatol Res (2004) 0.85
Mastocytosis: review of clinical and experimental aspects. J Investig Dermatol Symp Proc (2001) 0.85
Medium dose isotretinoin for the treatment of acne. J Eur Acad Dermatol Venereol (1998) 0.84
GM-CSF downmodulates c-kit, Fc(epsilon)RI(alpha) and GM-CSF receptor expression as well as histamine and tryptase levels in cultured human mast cells. Arch Dermatol Res (2001) 0.84
Human melanoma cell lines selected in vitro displaying various levels of drug resistance against cisplatin, fotemustine, vindesine or etoposide: modulation of proto-oncogene expression. Anticancer Res (1998) 0.84
Muckle-Wells syndrome: clinical and histological skin findings compatible with cold air urticaria in a large kindred. Br J Dermatol (2004) 0.84
Human mast cells produce and differentially express both soluble and membrane-bound stem cell factor. Scand J Immunol (1999) 0.83
Angiotensin II stimulates proliferation of primary human keratinocytes via a non-AT1, non-AT2 angiotensin receptor. Biochem Biophys Res Commun (1996) 0.83
Expression of SCF splice variants in human melanocytes and melanoma cell lines: potential prognostic implications. Br J Cancer (2000) 0.83
AP-2 gene expression and modulation by retinoic acid during keratinocyte differentiation. Biochem Biophys Res Commun (1996) 0.83
Neutrophilic urticaria: clinical features, histological changes and possible mechanisms. Br J Dermatol (1998) 0.83
Interactions of immature human mast cells with extracellular matrix: expression of specific adhesion receptors and their role in cell binding to matrix proteins. J Invest Dermatol (1996) 0.83
Regulation and possible function of axl expression in immature human mast cells. Ann Hematol (1998) 0.83
Effects of nerve growth factor (NGF) and other fibroblast-derived growth factors on immature human mast cells (HMC-1). Immunology (1998) 0.83
Expression of mast cell growth modulating and chemotactic factors and their receptors in human cutaneous scars. J Invest Dermatol (2001) 0.82
High-dose ultraviolet A1 (UVA1), but not UVA/UVB therapy, decreases IgE-binding cells in lesional skin of patients with atopic eczema. J Invest Dermatol (1996) 0.82
A subclone (5C6) of the human mast cell line HMC-1 represents a more differentiated phenotype than the original cell line. Arch Dermatol Res (1996) 0.82
Phacomatosis pigmentokeratotica: a patient with the rare melanocytic-epidermal twin nevus syndrome. Dermatology (1997) 0.82
The mast cell products histamine and serotonin stimulate and TNF-alpha inhibits the proliferation of murine epidermal keratinocytes in situ. J Dermatol Sci (1997) 0.81
Human leukemic (HMC-1) mast cells are responsive to 1alpha, 25-dihydroxyvitamin D(3): selective promotion of ICAM-3 expression and constitutive presence of vitamin D(3) receptor. Biochem Biophys Res Commun (2000) 0.81
Altered expression of mast cell chymase and tryptase and of c-Kit in human cutaneous scar tissue. J Invest Dermatol (2000) 0.81
Expression of MC1- and MC5-receptors on the human mast cell line HMC-1. Ann N Y Acad Sci (1999) 0.81
Retinoic acid inhibits CD40 plus IL-4 mediated IgE production through alterations of sCD23, sCD54 and IL-6 production. Inflamm Res (2005) 0.81
2,3,7,8-tetrachlorodibenzo-p-dioxin (TCCD) affects keratin 1 and keratin 17 gene expression and differentially induces keratinization in hairless mouse skin. J Invest Dermatol (1997) 0.81
Distribution and potential biologic function of the thrombin receptor PAR-1 on human keratinocytes. Arch Dermatol Res (2000) 0.80
Adhesion of human mast cells to extracellular matrix provides a co-stimulatory signal for cytokine production. Immunology (1999) 0.80
Anti-FcepsilonRIalpha serum autoantibodies in different subtypes of urticaria. Allergy (2000) 0.80
Nerve growth factor-beta induces mast-cell marker expression during in vitro culture of human umbilical cord blood cells. Immunology (2000) 0.80
Nuclear proto-oncogene products transactivate the human papillomavirus type 16 promoter. Br J Cancer (1995) 0.80
Enhanced P-selectin expression in chronic and dermographic urticaria. Int Arch Allergy Immunol (1997) 0.79
Mast cell and myeloid marker expression during early in vitro mast cell differentiation from human peripheral blood mononuclear cells. J Invest Dermatol (2000) 0.79
Effects of retinoids on in vitro and in vivo IgE production. Int Arch Allergy Immunol (2001) 0.79
Remission of epidermodysplasia verruciformis-like skin eruption after highly active antiretroviral therapy in a human immunodeficiency virus-positive patient. Br J Dermatol (2001) 0.79
Retinoic acid up-regulates myeloid ICAM-3 expression and function in a cell-specific fashion--evidence for retinoid signaling pathways in the mast cell lineage. J Leukoc Biol (2001) 0.78
Use of cetirizine in dermatologic disorders. Ann Allergy Asthma Immunol (1999) 0.78
Retinoic acids and dexamethasone alter cell-surface density of beta 2-integrins and ICAM-1 on human leukemic (HMC-1) mast cells. Arch Dermatol Res (1997) 0.78
Management of urticaria: a consensus report. J Investig Dermatol Symp Proc (2001) 0.78
Decreased cutaneous expression of stem cell factor and of the p75NGF receptor in urticaria. Br J Dermatol (2003) 0.78
Evidence for altered mast cell proliferation and apoptosis in cutaneous mastocytosis. Br J Dermatol (2003) 0.77
Adhesion molecules and cellular infiltrate: histology of urticaria. J Investig Dermatol Symp Proc (2001) 0.77